ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 235.8 GBX 2.25% Market Closed
Market Cap: 4.8B GBX
Have any thoughts about
ConvaTec Group PLC?
Write Note

Gross Margin
ConvaTec Group PLC

56%
Current
55%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
1.2B
/
Revenue
2.2B

Gross Margin Across Competitors

Country UK
Market Cap 4.8B GBP
Gross Margin
56%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.9B CHF
Gross Margin
55%
Country DK
Market Cap 200.9B DKK
Gross Margin
68%
Country US
Market Cap 16.9B USD
Gross Margin
70%
Country KR
Market Cap 9.9T KRW
Gross Margin
15%
Country CA
Market Cap 6.9B USD
Gross Margin
61%
Country CN
Market Cap 48.6B CNY
Gross Margin
73%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Country US
Market Cap 6.1B USD
Gross Margin
47%
Country CH
Market Cap 4.9B CHF
Gross Margin
35%
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.8B GBX
Industry
Health Care

ConvaTec Group PLC is a global medical technology company that specializes in the development and marketing of advanced products for wound care, ostomy care, continence care, and critical care. Founded in 1978 and headquartered in the UK, ConvaTec has established itself as a leader in the healthcare space, relentlessly focusing on innovative solutions that enhance patient outcomes and streamline healthcare delivery. With a diverse portfolio of trusted brands such as AQUACEL® and Versiva®, the company provides essential products that cater to the needs of patients with chronic, acute, and complex wounds as well as those requiring ostomy care. The company's growth trajectory has been bolstered by strategic investments in research and development, positioning it as a pioneer in integrating cutting-edge technologies into its offerings. As an investor, ConvaTec presents a compelling opportunity driven by increasing demand in the healthcare sector, notably due to an aging population, rising prevalence of chronic conditions, and heightened awareness of infection control. The company has demonstrated resilience and adaptability in navigating market fluctuations, evidenced by its strong revenue growth and operational improvements. With a robust pipeline of innovative products and a commitment to sustainability, ConvaTec is well-positioned to capitalize on emerging trends in healthcare. As healthcare evolves, its focus on delivering high-quality solutions not only enhances patient experiences but also promises to yield solid returns for investors looking to support the future of medical innovation.

CTEC Intrinsic Value
278.46 GBX
Undervaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
1.2B
/
Revenue
2.2B
What is the Gross Margin of ConvaTec Group PLC?

Based on ConvaTec Group PLC's most recent financial statements, the company has Gross Margin of 56%.